# COVID-19 ANtibody Responses in Cystic Fibrosis: CAR-CF

> **NCT05745948** · — · COMPLETED · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 75 (actual)

## Conditions studied

- COVID-19
- Cystic Fibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05745948
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-24
- **Primary completion:** 2025-12-15
- **Final completion:** 2025-12-15
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2026-02-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05745948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05745948, "COVID-19 ANtibody Responses in Cystic Fibrosis: CAR-CF". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT05745948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*